FDA Center for Biologics Evaluation & Research Issues Warning Letter to 4U Health
March 25, 2026
March 25, 2026
WASHINGTON, March 25 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to 4U Health from its Center for Biologics Evaluation and Research:
* * *
Recipient: Alfred Caminos, Co-Founder and Managing Director, 4U Health, 71 Lighthouse Road, Suite 220, Hilton Head Island, SC 29928, United States, help@4uhealth.com
Issuing Office: Center for Biologics Evaluation and Research (CBER), United States< . . .
* * *
Recipient: Alfred Caminos, Co-Founder and Managing Director, 4U Health, 71 Lighthouse Road, Suite 220, Hilton Head Island, SC 29928, United States, help@4uhealth.com
Issuing Office: Center for Biologics Evaluation and Research (CBER), United States< . . .